Methods to incorporate deuterium and tritium atoms into organic molecules are valuable for medicinal chemistry. The prevalence of pyridines and diazines in pharmaceuticals means that new Ways to label these heterocycles will present opportunities in drug design and facilitate absorption, distribution; metabolism, and excretion (ADME) studies. A broadly applicable protocol is presented wherein pyridines, diazines, and pharmaceuticals are converted into heterocyclic phosphonium salts and then isotopically labeled. The: isotopes are incorporated in high yields and, in general, with exclusive regioselectivity.
A general strategy for site-selective incorporation of deuterium and tritium into pyridines, diazines, and pharmaceuticals
Koniarczyk, J. L., Hesk, D., Overgard, A., Davies, I. W., & McNally, A. (2018). A general strategy for site-selective incorporation of deuterium and tritium into pyridines, diazines, and pharmaceuticals. Journal of the American Chemical Society, 140(6), 1990-1993. https://doi.org/10.1021/jacs.7b11710
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.
Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults
Use of a web-based portal to return normal individual research results in Early Check
The importance of quality data to track global progress in addressing stillbirths and neonatal mortality